CCL20 protein levels in serum measured in 224 NAFLD patients were increased in severe fibrosis (p < 0.001), with moderate correlation of hepatic transcript levels and serum levels. This evidence concerns the gene CCL20 and metabolic dysfunction-associated steatotic liver disease.